Prognosis for Stage I/II NSCLC

ABSTRACT: Eighty-four completely resected stage I/II non-small cell lung cancer (NSCLC) without adjuvant therapy were profiled using whole genome expression microarrys in order to identify novel classifications associated with RFS. Association with relapse-free survival (RFS) and clinicopathological parameters was assessed. An external cohort of 162 tumors was used to validate results.

ORGANISM(S): Homo sapiens

SUBMITTER: Julian Sanz Ortega 

PROVIDER: E-MTAB-1790 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress